semaglutide ckd approval FDA has approved Ozempic (semaglutide) to slow progression of chronic kidney disease in type 2 diabetes—first GLP‑1 under this indication, reducing risk by 24%. #glp_1 #GLP1 #CoreAgeRX #CoreAge #Core_Age_RX https://coreagerx.com Long-term kidney outcomes of semaglutide

PlexusDx's Precision Peptide Genetic Test reveals these genetic predispositions, allowing your provider to choose a dose strategy or alternative medication that suits your biology

Thats why weve expanded our services to include a range of IV treatments designed to meet diverse needs, including hydration, vitamin infusions, and specialized therapies for conditions like fatigue, migraines, and chronic illnesses

Experts often suggest starting around 250 mg glutathione (up to 1000 mg under doctor supervision)

Top-dose phentermine and topiramate was not cost-effective, with an ICER of $317,010 per QALY gained vs lifestyle counselling